Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site

Valuation: Biogen Inc.

Capitalization 18.43B 16.23B 15.12B 13.62B 25.32B 1,570B 28.39B 176B 68.99B 719B 69.13B 67.71B 2,628B P/E ratio 2025 *
11.3x
P/E ratio 2026 * 9.37x
Enterprise value 20.34B 17.9B 16.69B 15.03B 27.94B 1,732B 31.32B 194B 76.13B 794B 76.27B 74.71B 2,900B EV / Sales 2025 *
2.2x
EV / Sales 2026 * 1.92x
Free-Float
85.5%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.39%
1 week+0.18%
Current month+3.91%
1 month+6.47%
3 months-10.54%
6 months-20.32%
Current year-17.73%
More quotes
1 week 123.97
Extreme 123.97
131.13
1 month 115.25
Extreme 115.25
131.13
Current year 110.04
Extreme 110.035
157.09
1 year 110.04
Extreme 110.035
238
3 years 110.04
Extreme 110.035
319.76
5 years 110.04
Extreme 110.035
468.55
10 years 110.04
Extreme 110.035
468.55
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 2022-11-13
Director of Finance/CFO 59 2025-02-28
Chief Tech/Sci/R&D Officer 58 2023-10-01
Director TitleAgeSince
Chairman 65 2023-06-25
Director/Board Member 68 2010-03-22
Director/Board Member 76 2009-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.39%+0.18%-42.30%-36.91% 18.43B
-0.09%+1.89%-12.63%-9.80% 77.24B
-5.93%+1.60%+31.95%+24.05% 52.91B
-3.52%-2.33%+19.58%+86.57% 33.35B
-0.04%-.--%+98.69%+125.77% 14.02B
-0.15%+1.73%+73.75%+604.73% 12.59B
-0.41%+1.48%+11.83%-16.47% 12.44B
+4.18%+14.90%+58.38%+159.87% 12.34B
-0.42%+1.08%+4.26%-44.41% 12B
-0.79%-2.90%-24.18%-28.38% 11.04B
Average -0.76%+1.27%+21.93%+86.50% 25.64B
Weighted average by Cap. -1.62%+0.73%+13.86%+50.81%
See all sector performances

Financials

2025 *2026 *
Net sales 9.26B 8.15B 7.6B 6.84B 12.72B 788B 14.26B 88.28B 34.66B 361B 34.72B 34.01B 1,320B 9.12B 8.02B 7.48B 6.73B 12.52B 776B 14.04B 86.9B 34.11B 356B 34.18B 33.48B 1,299B
Net income 1.59B 1.4B 1.3B 1.17B 2.18B 135B 2.45B 15.16B 5.95B 62.05B 5.96B 5.84B 227B 1.92B 1.69B 1.58B 1.42B 2.64B 164B 2.96B 18.35B 7.2B 75.11B 7.22B 7.07B 274B
Net Debt 1.91B 1.68B 1.56B 1.41B 2.62B 162B 2.94B 18.17B 7.13B 74.37B 7.15B 7B 272B -888M -782M -729M -656M -1.22B -75.66B -1.37B -8.47B -3.33B -34.67B -3.33B -3.26B -127B
More financial data * Estimated data
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (74.6%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (6.7%) ; - other (18.7%): primarily revenues from partnership agreements.
Employees
7,605
More about the company
Date Price Change Volume
25-05-23 125.81 $ -0.39% 837,407
25-05-22 126.30 $ -0.41% 937,041
25-05-21 126.82 $ -2.86% 1,593,947
25-05-20 130.55 $ +0.86% 1,684,915
25-05-19 129.44 $ +3.07% 2,387,543

Delayed Quote Nasdaq, May 23, 2025 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
125.81USD
Average target price
171.95USD
Spread / Average Target
+36.67%
Consensus

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
BENEFIT NOW